ATE279944T1 - Kombinationsimpfstoff zur steigerung der immunität gegen brucellose - Google Patents
Kombinationsimpfstoff zur steigerung der immunität gegen brucelloseInfo
- Publication number
- ATE279944T1 ATE279944T1 AT00127372T AT00127372T ATE279944T1 AT E279944 T1 ATE279944 T1 AT E279944T1 AT 00127372 T AT00127372 T AT 00127372T AT 00127372 T AT00127372 T AT 00127372T AT E279944 T1 ATE279944 T1 AT E279944T1
- Authority
- AT
- Austria
- Prior art keywords
- ops
- immunity against
- different
- combination vaccine
- increase immunity
- Prior art date
Links
- 206010006500 Brucellosis Diseases 0.000 title abstract 2
- 230000036039 immunity Effects 0.000 title abstract 2
- 229940001442 combination vaccine Drugs 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 2
- 241000589562 Brucella Species 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000589567 Brucella abortus Species 0.000 abstract 1
- 241001148111 Brucella suis Species 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1221—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Brucella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/098—Brucella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17076599P | 1999-12-15 | 1999-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279944T1 true ATE279944T1 (de) | 2004-11-15 |
Family
ID=22621165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00127372T ATE279944T1 (de) | 1999-12-15 | 2000-12-13 | Kombinationsimpfstoff zur steigerung der immunität gegen brucellose |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6582699B2 (de) |
| EP (1) | EP1108433B1 (de) |
| AT (1) | ATE279944T1 (de) |
| AU (1) | AU780331B2 (de) |
| CA (1) | CA2328321C (de) |
| DE (1) | DE60015058T2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7364745B2 (en) * | 2004-02-06 | 2008-04-29 | Virginia Tech Intellectual Properties, Inc. | Development of a live, attenuated, recombinant vaccine for Brucellosis |
| GB0724668D0 (en) * | 2007-12-19 | 2008-01-30 | Secr Defence | Vaccines for Brucellosis |
| RU2484481C1 (ru) * | 2011-09-30 | 2013-06-10 | Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) | Способ получения эритроцитарного антигена для реакции непрямой гемагглютинации при бруцеллезе |
| KR101753580B1 (ko) * | 2015-08-24 | 2017-07-06 | 대한민국 | 브루셀라 캐니스 항원의 제조 방법 |
| CN108359009B (zh) * | 2017-12-28 | 2021-06-04 | 吉林医药学院 | 布鲁氏菌单链抗体及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2849632B2 (ja) * | 1988-04-08 | 1999-01-20 | 社団法人北里研究所 | ワクチン製剤 |
| BR9305970A (pt) * | 1992-02-25 | 1997-10-21 | Texas A & M Univ Sys | Vacina aperfeiçoada contra brucella abortus |
| US5951987A (en) * | 1995-08-22 | 1999-09-14 | Her Majesty The Queen As Represented By The Minister Of National Defence Of Her Majesty'canadian Government | Polysaccharide vaccine to enhance immunity against brucellosis |
| US6444210B1 (en) * | 1996-07-03 | 2002-09-03 | Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence of Her Majesty′s Canadian Goverment | Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity |
-
2000
- 2000-12-13 DE DE60015058T patent/DE60015058T2/de not_active Expired - Lifetime
- 2000-12-13 EP EP00127372A patent/EP1108433B1/de not_active Expired - Lifetime
- 2000-12-13 AT AT00127372T patent/ATE279944T1/de not_active IP Right Cessation
- 2000-12-13 CA CA2328321A patent/CA2328321C/en not_active Expired - Fee Related
- 2000-12-14 US US09/735,534 patent/US6582699B2/en not_active Expired - Fee Related
- 2000-12-15 AU AU72309/00A patent/AU780331B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2328321A1 (en) | 2001-06-15 |
| US20020122808A1 (en) | 2002-09-05 |
| EP1108433A2 (de) | 2001-06-20 |
| US6582699B2 (en) | 2003-06-24 |
| AU780331B2 (en) | 2005-03-17 |
| CA2328321C (en) | 2011-02-08 |
| EP1108433B1 (de) | 2004-10-20 |
| DE60015058T2 (de) | 2006-02-16 |
| EP1108433A3 (de) | 2003-06-25 |
| DE60015058D1 (de) | 2004-11-25 |
| AU7230900A (en) | 2001-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1153761A1 (zh) | 以腫瘤抑制基因 的產物作為腫瘤抗原 | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| DE60310562D1 (de) | Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen | |
| ES2180651T3 (es) | Vacuna que contiene acidos nucleicos. | |
| CY1109531T1 (el) | Πρωτεϊνες συντηξης του μυκοβακτηριδιου της φυματιωσης | |
| WO2001064920A3 (en) | Hybrid expression of neisserial proteins | |
| ATE378403T1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
| FR2741806B1 (fr) | Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline | |
| FR21C1005I2 (fr) | Antigenes de streptococcus pyogenes et fragments d'adn correspondants | |
| ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
| DE69419966D1 (de) | Impstoff gegen Streptococcus suis-Infektion | |
| ATE345354T1 (de) | Methode zur identifizierung von helicobacter antigenen | |
| ATE279944T1 (de) | Kombinationsimpfstoff zur steigerung der immunität gegen brucellose | |
| WO1999004011A3 (en) | Hiv-1 group o antigens and uses thereof | |
| DE69836520D1 (de) | Clostridium perfringens Impfstoff | |
| DE69402201D1 (de) | Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen | |
| SE9602822D0 (sv) | New receptor | |
| DK1416956T3 (da) | Autologe T-celle-vaccinematerialer samt fremgangsmåde til deres fremstilling | |
| MY137258A (en) | Bacterial insecticidal protein | |
| WO2002077648A3 (en) | Pathogenic and commensal vaccine antigens | |
| WO2004003009A3 (en) | Francisella tularensis immunogenic proteins and dna encoding these | |
| DE69119785D1 (de) | Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen | |
| SE9604439D0 (sv) | New receptor | |
| DE59914550D1 (de) | Synthetisches nukleinsäure-partikel | |
| DE60307296D1 (de) | Verfahren zur herstellung von vitamin-b6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |